Reactive oxygen species enhances the induction of inducible nitric oxide synthase by sphingomyelinase in RAW264.7 cells

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1393, Issue 1, 1998, Pages 203-210

  Hatanaka, Yutaka ^a   Fujii, Junichi ^a   Fukutomi, Tatsushi ^a   Watanabe, Toshiya ^a   Che, Wenyi ^a   Sanada, Yasuhiro ^a   Igarashi, Yasuyuki ^b   Taniguchi, Naoyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Faculty of Pharmaceutical Sciences   (Japan)

Author keywords

Antioxidant; Nitric oxide; Nitric oxide synthase; Reactive oxygen species; Sphingomyelinase

Indexed keywords

NITRIC OXIDE SYNTHASE; NITRITE; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; FLOW CYTOMETRY; GENE INDUCTION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CELL SURVIVAL; ENZYME INDUCTION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

EID: 0032584532     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00066-6     Document Type: Article

References (39)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
2. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261:1993;1445-1448.
3. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1555.
4. Stadler J., Curran R.D., Ochoa J.B., Harbrecht B.G., Hoffman R.A., Simmons R.L., Billiar T.R. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch. Surg. 126:1991;186-191.
5. Asahi M., Fujii J., Suzuki K., Seo H.G., Kuzuya T., Hori M., Tada M., Fujii S., Taniguchi N. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J. Biol. Chem. 270:1995;21035-21039.
6. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishuok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
7. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes. 44:1995;733-738.
8. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
9. Xie Q., Kashiwabara Y., Nathan C. Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
10. Spink J., Cohen J., Evans T.J. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-κB. J. Biol. Chem. 270:1995;29541-29547.
11. Kleinert H., Euchenhofer C., Ihrig-Biedert I., Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 49:1996;15-21.
12. Kim M.Y., Linardic C., Obeid L., Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon. Specific role in cell differentiation. J. Biol. Chem. 266:1991;484-489.
13. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:1994;325-328.
14. Liu J., Mathias S., Yang Z., Kolesnick R.N. Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269:1994;3047-3052.
15. Machleidt T., Wiegmann K., Henkel T., Schutze S., Baeuerle P., Krönke M. Sphingomyelinase activates proteolytic IκBα degradation in a cell-free system. J. Biol. Chem. 269:1994;13760-13765.
16. Yang Z., Costanzo M., Golde adn D.W., Kolesnick R.N. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J. Biol. Chem. 268:1993;20520-20523.
17. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271:1996;8307-8312.
18. Yamauchi N., Kuriyama H., Watanabe N., Neda H., Maeda M., Niitsu Y. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49:1989;1671-1675.
19. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
20. Slotte J.P., Harmala A.S., Jansson C., Porn M.I. Rapid turn-over of plasma membrane sphingomyelin and cholesterol in baby hamster kidney cells after exposure to sphingomyelinase. Biochim. Biophys. Acta. 1030:1990;251-257.
21. Gupta A.K., Rudney H. Sphingomyelinase treatment of low density lipoprotein and cultured cells results in enhanced processing of LDL which can be modulated by sphingomyelin. J. Lipid Res. 33:1992;1741-1752.
22. 15N]nitrate in biological fluids. Anal. Biochem. 26:1982;131-138.
23. Yamazaki S., Onishi E., Enami K., Natori K., Kohase M., Sakamoto H., Tanouchi M., Hayashi H. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Jpn. J. Med. Sci. Biol. 39:1986;105-118.
24. Kayanoki Y., Fujii J., Suzuki K., Kawata S., Matsuzawa Y., Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-β1 in rat hepatocytes. J. Biol. Chem. 269:1994;15488-15492.
25. Seo H.G., Tatsumi H., Fujii J., Nishikawa A., Suzuki K., Kangawa K., Taniguchi N. Nitric oxide synthase from rat colorectum: purification, peptide sequencing, partial PCR cloning, and immunohistochemistry. J. Biochem. 115:1994;602-607.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
27. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
28. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
29. Yanaga F., Watson S.P. Ceramide does not mediate the effect of tumour necrosis factor α on superoxide generation in human neutrophils. Biochem. J. 298:1994;733-738.
30. Turinsky J., Nagel G.W., Elmendorf J.S., Damrau-Abney A., Smith T.R. Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem. J. 313:1996;215-222.
31. Wong G.H.W., Elwell J.H., Oberley L.W., Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
32. Masuda A., Longo D.L., Kobayashi Y., Appella E., Oppenheim J.J., Matsushima K. Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J. 2:1988;3087-3091.
33. Nakamura T., Abe A., Balazovich K.J., Wu D., Suchard S.J., Boxer A.B., Shayman J.S. Ceramide regulates oxidant release in adherent human neutrophils. J. Biol. Chem. 269:1994;18384-18389.
34. Greenlund L.J., Deckwerth T.L., Johnson E.M. Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
35. 2+ ionophore-induced apoptosis in cultured rat cortical neurons. Biochem. Biophys. Res. Commun. 227:1996;513-518.
36. 2-terminal kinases. J. Biol. Chem. 271:1996;15703-15707.
37. Mendelson K.G., Contois L.R., Tevosian S.G., Davis R.J., Paulson K.E. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. USA. 93:1996;12908-12913.
38. Verheij M., Bose R., Lin X.H., Yao B., Jarus W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolensnick R.N. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature. 380:1996;75-79.
39. Koide M., Kawahara Y., Nakayama I., Tsuda T., Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem. 268:1993;24959-24966.